[1]
|
Terry, P.D. and Dhand, R. (2020) Inhalation Therapy for Stable COPD: 20 Years of GOLD Reports. Advances in Therapy, 37, 1812-1828. https://doi.org/10.1007/s12325-020-01289-y
|
[2]
|
Jimenez, D., Agusti, A., Monreal, M., et al. (2019) The Rationale, Design, and Methods of a Randomized, Controlled Trial to Evaluate the Efficacy and Safety of an Active Strategy for the Diagnosis and Treatment of Acute Pulmonary Embolism during Exacerbations of Chronic Obstructive Pulmonary Disease. Clinical Cardiology, 42, 346-351. https://doi.org/10.1002/clc.23161
|
[3]
|
Wang, J., Wan, Z., Liu, Q., et al. (2020) Predictive Value of Red Blood Cell Distribution Width in Chronic Obstructive Pulmonary Disease Patients with Pulmonary Embolism. Analytical Cellular Pathology, 2020, Article ID: 1935742. https://doi.org/10.1155/2020/1935742
|
[4]
|
Borvik, T., Braekkan, S.K., Enga, K., et al. (2016) COPD and Risk of Venous Thromboembolism and Mortality in a General Population. European Respiratory Journal, 47, 473-481. https://doi.org/10.1183/13993003.00402-2015
|
[5]
|
Zvezdin, B., Milutinov, S., Kojicic, M., et al. (2009) A Postmortem Analysis of Major Causes of Early Death in Patients Hospitalized with COPD Exacerbation. Chest, 136, 376-380. https://doi.org/10.1378/chest.08-2918
|
[6]
|
Pourmand, A., Robinson, H., Mazer-Amirshahi, M., et al. (2018) Pulmonary Embolism among Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease: Implications for Emergency Medicine. Journal of Emergency Medicine, 55, 339-346. https://doi.org/10.1016/j.jemermed.2018.05.026
|
[7]
|
Aleva, F.E., Voets, L., Simons, S.O., et al. (2017) Prevalence and Localization of Pulmonary Embolism in Unexplained Acute Exacerbations of COPD: A Systematic Review and Meta-Analysis. Chest, 151, 544-554. https://doi.org/10.1016/j.chest.2016.07.034
|
[8]
|
华晶, 韩蕙泽, 季颖群. 慢性阻塞性肺疾病合并肺栓塞的评估及处置[J]. 中国实用内科杂志, 2020, 40(10): 800-804.
|
[9]
|
Akpinar, E.E., Hosgun, D., Akpinar, S., et al. (2014) Incidence of Pulmonary Embolism during COPD Exacerbation. Jornal Brasileiro de Pneumologia, 40, 38-45. https://doi.org/10.1590/S1806-37132014000100006
|
[10]
|
Rizkallah, J., Man, S. and Sin, D.D. (2009) Prevalence of Pulmonary Embolism in Acute Exacerbations of COPD: A Systematic Review and Metaanalysis. Chest, 135, 786-793. https://doi.org/10.1378/chest.08-1516
|
[11]
|
Shapira-Rootman, M., Beckerman, M., Soimu, U., et al. (2015) The Prevalence of Pulmonary Embolism among Patients Suffering from Acute Exacerbations of Chronic Obstructive Pulmonary Disease. Emergency Radiology, 22, 257-260. https://doi.org/10.1007/s10140-014-1280-7
|
[12]
|
Pourmand, A., Robinson, H., Mazer-Amirshahi, M., et al. (2018) Pulmonary Embolism among Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease: Implications for Emergency Medicine. Journal of Emergency Medicine, 55, 339-346. https://doi.org/10.1016/j.jemermed.2018.05.026
|
[13]
|
Choi, K.J., Cha, S.I., Shin, K.M., et al. (2013) Prevalence and Predictors of Pulmonary Embolism in Korean Patients with Exacerbation of Chronic Obstructive Pulmonary Disease. Respiration, 85, 203-209. https://doi.org/10.1159/000335904
|
[14]
|
Dutt, T.S. and Udwadia, Z.F. (2011) Prevalence of Venous Thromboembolism in Acute Exacerbations of Chronic Obstructive Pulmonary Disease: An Indian Perspective. The Indian Journal of Chest Diseases and Allied Sciences, 53, 207-210. https://doi.org/10.5005/ijcdas-53-4-207
|
[15]
|
Pang, H., Wang, L., Liu, J., et al. (2018) The Prevalence and Risk Factors of Venous Thromboembolism in Hospitalized Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease. The Clinical Respiratory Journal, 12, 2573-2580. https://doi.org/10.1111/crj.12959
|
[16]
|
Cao, Y.Q., Dong, L.X. and Cao, J. (2018) Pulmonary Embolism in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease. Chinese Medical Journal, 131, 1732-1737. https://doi.org/10.4103/0366-6999.235865
|
[17]
|
Hassen, M.F., Tilouche, N., Jaoued, O., et al. (2019) Incidence and Impact of Pulmonary Embolism during Severe COPD Exacerbation. Respiratory Care, 64, 1531-1536. https://doi.org/10.4187/respcare.06661
|
[18]
|
龚娟妮. 《肺血栓栓塞症诊治与预防指南》解读——诊断策略推荐[J]. 中国医刊, 2018, 53(10): 1072-1076.
|
[19]
|
李积凤, 杨媛华. 《肺血栓栓塞症诊治与预防指南》——关于静脉血栓栓塞症预防的推荐意见[J]. 中国医刊, 2018, 53(10): 1078-1082.
|
[20]
|
Saghazadeh, A. and Rezaei, N. (2016) Inflammation AS A Cause of Venous Thromboembolism. Critical Reviews in Oncology/Hematology, 99, 272-285. https://doi.org/10.1016/j.critrevonc.2016.01.007
|
[21]
|
Nathan, S.D., Barbera, J.A., Gaine, S.P., et al. (2019) Pulmonary Hypertension in Chronic Lung Disease and Hypoxia. European Respiratory Journal, 53, Article ID: 1801914. https://doi.org/10.1183/13993003.01914-2018
|
[22]
|
Vaidyula, V.R., Criner, G.J., Grabianowski, C., et al. (2009) Circulating Tissue Factor Procoagulant Activity Is Elevated in Stable Moderate to Severe Chronic Obstructive Pulmonary Disease. Thrombosis Research, 124, 259-261. https://doi.org/10.1016/j.thromres.2008.12.030
|
[23]
|
邵斌霞, 王玮, 何斌, 等. 吸烟与急性肺栓塞危险分层及严重程度的相关性[J]. 中西医结合心脑血管病杂志, 2023, 21(11): 2032-2036.
|
[24]
|
Boag, S.E., Das, R., Shmeleva, E.V., et al. (2015) T Lymphocytes and Fractalkine Contribute to Myocardial Ischemia/Reperfusion Injury in Patients. Journal of Clinical Investigation, 125, 3063-3076. https://doi.org/10.1172/JCI80055
|
[25]
|
韩静, 刘晓宇, 翁军, 等. 慢性阻塞性肺疾病急性加重期患者血清CTRP-5、FKN水平变化及其临床意义[J]. 山东医药, 2020, 60(34): 15-19.
|
[26]
|
Szukiewicz, D., Kochanowski, J., Mittal, T.K., et al. (2014) CX3CL1 (Fractalkine) and TNFalpha Production by Perfused Human Placental Lobules under Normoxic and Hypoxic Conditions in Vitro: The Importance of CX3CR1 Signaling. Inflammation Research, 63, 179-189. https://doi.org/10.1007/s00011-013-0687-z
|
[27]
|
张龙举, 刘晓丽. 慢性阻塞性肺疾病患者血清ADAM-17与趋化因子FKN的变化及意义[J]. 吉林医学, 2012, 33(4): 700-702.
|
[28]
|
Flierl, U., Bauersachs, J. and Schafer, A. (2015) Modulation of Platelet and Monocyte Function by the Chemokine Fractalkine (CX3 CL1) in Cardiovascular Disease. European Journal of Clinical Investigation, 45, 624-633. https://doi.org/10.1111/eci.12443
|
[29]
|
Hao, W., Li, M., Zhang, C., et al. (2019) High Serum Fractalkine/CX3CL1 in Patients with Chronic Obstructive Pulmonary Disease: Relationship with Emphysema Severity and Frequent Exacerbation. Lung, 197, 29-35. https://doi.org/10.1007/s00408-018-0176-9
|
[30]
|
Chowdhury, S.R., Ray, U., Chatterjee, B.P., et al. (2017) Targeted Apoptosis in Ovarian Cancer Cells through Mitochondrial Dysfunction in Response to Sambucus Nigra Agglutinin. Cell Death & Disease, 8, e2762. https://doi.org/10.1038/cddis.2017.77
|
[31]
|
Schwarz, N., Pruessmeyer, J., Hess, F.M., et al. (2010) Requirements for Leukocyte Transmigration via the Transmembrane Chemokine CX3CL1. Cellular and Molecular Life Sciences, 67, 4233-4248. https://doi.org/10.1007/s00018-010-0433-4
|
[32]
|
Ostrowski, R.P., Jadhav, V., Chen, W., et al. (2010) Reduced Matrix Metalloproteinase-9 Activity and Cell Death after Global Ischemia in the Brain Preconditioned with Hyperbaric Oxygen. In: Czernicki, Z., Baethmann, A., Ito, U., Katayama, Y., Kuroiwa, T. and Mendelow, D., Eds., Brain Edema XIV, Springer, Vienna, 47-49. https://doi.org/10.1007/978-3-211-98811-4_7
|
[33]
|
Verhamme, F.M., Freeman, C.M., Brusselle, G.G., et al. (2019) GDF-15 in Pulmonary and Critical Care Medicine. American Journal of Respiratory Cell and Molecular Biology, 60, 621-628. https://doi.org/10.1165/rcmb.2018-0379TR
|
[34]
|
Ratnam, N.M., Peterson, J.M., Talbert, E.E., et al. (2017) NF-κB Regulates GDF-15 to Suppress Macrophage Surveillance during Early Tumor Development. Journal of Clinical Investigation, 127, 3796-3809. https://doi.org/10.1172/JCI91561
|
[35]
|
Huh, S.J., Chung, C.Y., Sharma, A., et al. (2010) Macrophage Inhibitory Cytokine-1 Regulates Melanoma Vascular Development. The American Journal of Pathology, 176, 2948-2957. https://doi.org/10.2353/ajpath.2010.090963
|
[36]
|
陈丽. 不同病情程度的急性肺栓塞患者血清GDF-15、BNP水平变化及临床意义[J]. 首都食品与医药, 2020, 27(3): 134-135.
|
[37]
|
Tsiligianni, I. and Kaplan, A.G. (2018) Are Blood Eosinophils a Prime-Time Biomarker for COPD Management Decisions? International Journal of Chronic Obstructive Pulmonary Disease, 13, 1889-1891. https://doi.org/10.2147/COPD.S163749
|
[38]
|
David, B., Bafadhel, M., Koenderman, L., et al. (2021) Eosinophilic Inflammation in COPD: From an Inflammatory Marker to a Treatable Trait. Thorax, 76, 188-195. https://doi.org/10.1136/thoraxjnl-2020-215167
|
[39]
|
Bafadhel, M., McKenna, S., Terry, S., et al. (2011) Acute Exacerbations of Chronic Obstructive Pulmonary Disease: Identification of Biologic Clusters and Their Biomarkers. American Journal of Respiratory and Critical Care Medicine, 184, 662-671. https://doi.org/10.1164/rccm.201104-0597OC
|
[40]
|
Gutmann, C., Siow, R., Gwozdz, A.M., et al. (2020) Reactive Oxygen Species in Venous Thrombosis. International Journal of Molecular Sciences, 21, Article 1918. https://doi.org/10.3390/ijms21061918
|
[41]
|
Maritano, F.J., Castro, H.M., De Vito, E.L., et al. (2020) Diagnosis of Pulmonary Embolism in Patients with Acute Exacerbations of Chronic Obstructive Pulmonary Disease: A Cross-Sectional Study. The Clinical Respiratory Journal, 14, 1176-1181. https://doi.org/10.1111/crj.13257
|
[42]
|
Rodriguez, C., Jara-Palomares, L., Tabernero, E., et al. (2022) Adjusted D-Dimer Cutoff Levels to Rule out Pulmonary Embolism in Patients Hospitalized for COPD Exacerbation: Results from the SLICE Trial. Thrombosis Journal, 20, Article No. 10. https://doi.org/10.1186/s12959-022-00368-0
|
[43]
|
Gunen, H., Gulbas, G., In, E., et al. (2010) Venous Thromboemboli and Exacerbations of COPD. European Respiratory Journal, 35, 1243-1248. https://doi.org/10.1183/09031936.00120909
|
[44]
|
Sadeghi, S., Emami, A.M., Raofi, E., et al. (2020) Diagnostic Value of D-Dimer in Detecting Pulmonary Embolism in Patients with Acute COPD Exacerbation. Tanaffos, 19, 371-379.
|
[45]
|
Peng, L., Han, L., Li, X.N., et al. (2020) The Predictive Value of MicroRNA-134 and MicroRNA-1233 for the Early Diagnosis of Acute Exacerbation of Chronic Obstructive Pulmonary Disease with Acute Pulmonary Embolism. International Journal of Chronic Obstructive Pulmonary Disease, 15, 2495-2503. https://doi.org/10.2147/COPD.S266021
|
[46]
|
Nafady, A., Rashad, A., Nafady-Hego, H., et al. (2022) Clinical Significance of MiRNA-145 and-126 in Chronic Obstructive Pulmonary Disease with Pulmonary Embolism. Clinical Laboratory, 68. https://doi.org/10.7754/Clin.Lab.2021.211113
|
[47]
|
Zhang, Y., Zhang, Z., Wei, R., et al. (2020) IL (Interleukin)-6 Contributes to Deep Vein Thrombosis and Is Negatively Regulated by MiR-338-5p. Arteriosclerosis, Thrombosis, and Vascular Biology, 40, 323-334. https://doi.org/10.1161/ATVBAHA.119.313137
|
[48]
|
Zhu, Y.Q., Ma, S.P., Dong, W.G., et al. (2019) [Correlation between Serum Interleukin-38 and Acute Exacerbation of Chronic Obstructive Pulmonary Disease with Pulmonary Embolism]. Chinese Medical Journal, 99, 929-933.
|